BractonDeal Intel
Get full access
AcquisitionOther

Landos Biopharma, Inc. acquired Landos Biopharma, Further Strengthening

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Landos Biopharma, Inc. -> Landos Biopharma, Further Strengthening · $20.42

AbbVie strives to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in AbbVie’s Allergan Aesthetics portfolio.

Open source record (SEC) ↗